Back to search results

Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism

Abroad (travel likely)Recruiting

Conditions

Cancer · Venous Thromboembolism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Danderyd Hospital, Stockholm, Sweden

    Contact: Study coordinator (Charlotte Thålin, M.D., Ph.D.) · charlotte.thalin@sll.se · +46709565120
    Contact: Study coordinator (Lena Gabrielsson) · lena.gabrielsson@sll.se · +46737121286
    Contact: Principal Investigator (Charlotte Thålin, M.D., Ph.D.)
    Contact: Principal Investigator (Håkan Wallén, M.D., Prof.)

  • Södersjukhuset, Stockholm, Sweden

    Contact: Study coordinator (Mårten Söderberg, M.D., Ph.D.) · marten.soderberg@sll.se · +4686160000
    Contact: Principal Investigator (Charlotte Thålin, M.D., Ph.D.)
    Contact: Principal Investigator (Håkan Wallén, M.D., Prof.)
Study leads

  • Charlotte Thålin, M.D., Ph.D.

    Principal Investigator

    Karolinska Institutet

  • Håkan Wallén, M.D., Prof.

    Principal Investigator

    Karolinska Institutet

View source on ClinicalTrials.gov(opens in a new tab)